Essex Investment Management CO LLC Processa Pharmaceuticals, Inc. Transaction History

Essex Investment Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.68 - $3.55 $3,864 - $8,165	2,300 New	2,300 $6,000
Q1 2022 May 09, 2022	SELL	$3.01 - $5.21 $220,271 - $381,267	-73,180 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$4.03 - $8.42 $4,698 - $9,817	-1,166 Reduced 1.57%	73,180 $359,000
Q3 2021 Nov 09, 2021	BUY	$5.28 - $8.61 $7,592 - $12,381	1,438 Added 1.97%	74,346 $637,000
Q1 2021 May 12, 2021	SELL	$5.96 - $13.15 $12,039 - $26,563	-2,020 Reduced 2.7%	72,908 $795,000
Q4 2020 Feb 12, 2021	BUY	$3.95 - $8.48 $295,965 - $635,389	74,928 New	74,928 $494,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $14.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.